
Former FDA Chief Scientist, Jesse L. Goodman, MD, MPH, provides insights on the potential consequences of these new recommendations.
Goodman is director of Center on Medical Product Access, Safety and Stewardship (COMPASS) Georgetown University, and a former FDA chief scientist.

Former FDA Chief Scientist, Jesse L. Goodman, MD, MPH, provides insights on the potential consequences of these new recommendations.